Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

BioSure UK’s home HIV test goes on sale in the UK

Test delivers a diagnosis in just 15 minutes

- PMLiVE

Virgo Consumer Health & Wellbeing hires Kirsty McKinnon

Med comms agency strengthens senior team with new personal care sector lead

- PMLiVE

BIA says action plan could quadruple R&D output by 2025

Claims it could rank the UK in the global top three largest biotech clusters

- PMLiVE

Mylan pulls no punches in rejecting Teva takeover

Firm calls Israeli generics giant’s credibility into question

Sanofi reception

Sanofi gains accelerated review for rare disease drug

New pill for Fabry disease could be approved by the FDA before the end of the year

- PMLiVE

apceth names Ulrike Verzetnitsch as chief technical officer

She joins from Takeda, with immediate effect

- PMLiVE

Payment to docs rules ‘an opportunity for pharma’

The industry’s reputation can be boosted by openness, say pharma compliance leaders

Celgene building

Celgene to acquire biotech firm Quanticel Pharmaceuticals

Firm hopes to expand its pipeline of life-enhancing products for cancer patients

- PMLiVE

INC Research and DrugDev collaborate to push clinical trials

Aims to create cloud-based solutions to boost efficacy

- PMLiVE

Is a UK market access shake-up on the cards?

Former coalition government health minister Paul Burstow tells PMLiVE that NICE, QALY and broader issues of market access in England are all being put under review

Pharma deals in February 2015

Pfizer and Valeant led the way during a respectable, if not record-breaking, month for mergers, acquisitions and collaborations

Medius Deal Watch table for February 2015

The top major pharma mergers, acquisitions and collaborations during the month were led by the Pfizer/Hospira and Salix/Valeant deals

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links